U.S. Department of Agriculture
Food Safety and Inspection Service
Washington, DC 20250
|Albendazole - Halofuginone | HCB - Zinc | References|
| COMPOUND | Method Description |
LDL/ MIC |
MPL |
Species/ Tissues |
Reference |
HCB |
Micro alumina assay: column chromatography plus GLC |
0.01 ppm |
NE |
All/fat |
1 |
GPC plus GLC Mills method: Florisil column chromatography plus GLC |
0.01 ppm 0.01 ppm |
0.05 ppm 0.10 ppm |
All/fat All/fat,PP |
1 1 |
|
Extracts from GPC or Mills are confirmed by GC/ MS |
0.01 ppm |
NE |
All/fat,PP |
1 |
|
Heptachlor and heptachlor epoxide |
Micro alumina assay: column chromatography plus GLC |
0.01 ppm |
NE |
All/fat, PP |
1 |
GPC plus GLC Mills method: Florisil column chromatography plus GLC |
0.01 ppm 0.01 ppm |
0.05 ppm 0.10 ppm |
All/fat All/fat, PP |
1 1 |
|
Extracts from GPC or Mills are confirmed by GC/MS |
0.02 ppm |
NE |
All/fat,pp |
1 |
|
Hetacillin, Potassium |
Antibiotic screen test (Swab): ability of tissue fluids containing anti- microbial activity to inhibit microbial growth |
NE |
NE |
All/kidney |
16 |
5-Hydroxy- thiabendazole |
Extraction with organic solvents followed by HPLC withUV detection; extracts confirmed by derivatized GC/EI/MS |
0.05 ppm |
NE |
Red meat/ liver, muscle |
14 |
Hygromycin B |
Antibiotic screen test (Swab):ability of tissue fluids containing antimicrobial activity toinhibit microbial growth |
5.00 ppm |
NE |
All/kidney |
16 |
Ipronidazole and hydroxy metabolite |
Tissue extracts are quantified by HPLC/UV |
1.0 ppb |
NE |
Turkey, swine/ muscle |
14 |
Tissue extracts from HPLC are confirmed by GC/NICI/MS |
1.0 ppb |
NE |
Turkey, swine muscle |
14 |
|
Iron |
Dry ashed tissue is dissolved and quantified by AAS or by inductively coupled plasma |
3.0 ppb
|
NE
|
All/kidney, liver, muscle |
1 |
| COMPOUND | Method Description |
LDL/ MIC |
MPL |
Species/ Tissues |
Reference |
Ivermectin |
Tissue extracts are quantified by HPLC fluorescence |
2 ppb |
5 ppb |
Red meat/ liver, muscle |
1 |
Derivatization to form 3 components with detection by HPLC fluorescence |
2 ppb |
NE |
Red meat/ liver, muscle |
1 |
|
Lasalocid |
Tissue extracts are quantified by HPLC fluorescence detector |
0.025 ppm 0.025 ppm |
0.35 ppm NE |
Cattle/liver Poultry/fat, skin |
1 24 |
Tissue extraction followed by bioautography |
0.005 ppm |
0.01 ppm |
Poultry/fat, skin |
24 |
|
GC pyrolysis of the HPLCextract with MS identification of the fragments |
0.2 ppm |
NE |
Cattle/liver; Poultry/fat, skin |
24 |
|
Lead |
Dry ashed tissue is dissolved and quantified by AAS or by inductively coupled plasma |
0.01 ppm 0.05 ppm |
NE NE |
All/kidney liver, muscle |
1
|
Dry ashed tissue is quantified by anodic stripping voltammetry |
1.0 ppb |
NE |
Poultry/ kidney, liver |
7 |
|
Levamisole |
Tissue extracts are quantified by GLC flame photometric detection |
0.05 ppm |
NE |
Red meat/ liver, muscle |
1 |
Tissue extracts are subjected to GC/MS |
0.05 ppm |
NE |
Red meat/ liver, muscle |
1 |
|
Lincomycin hydrochloride |
Microbiological assay procedure: ability of tissue extracts containing antimicrobial activity toinhibit microbial growth |
0.10 ppm |
0.10 ppm |
Poultry, swine/all |
25 |
Lindane |
Micro alumina assay: column chromatography plus GLC |
0.01 ppm |
NE |
All/fat,PP |
1 |
GPC plus GLC Mills method: Florisil column chromatography plus GLC |
0.01 ppm 0.01 ppm |
0.05 ppm 0.10 ppm |
All/fat All/fat,PP |
1 1 |
|
Extracts from GPC or Mills are confirmed by GC/MS |
0.01 ppm |
NE |
All/fat,PP |
1 |
|
Linuron |
GPC plus GLC Extracts are confirmed by GC/EI/MS |
0.25 ppm 0.05 ppm |
0.50 ppm NE |
All/fat Red meat/ fat |
1 1 |
| COMPOUND | Method Description |
LDL/ MIC |
MPL |
Species/ Tissues |
Reference |
Lysergic acid diethylamide |
Tissue extracts are spotted forTLC and detected with specific chromagenic reagent |
NE |
NE |
All/kidney, liver, muscle |
1 |
Malathion |
Tissue extracts are quantified by GLC with flame photometric muscle or nitrogen-phosphorous flame ionization detector |
0.10 ppm |
NE |
All/liver, |
1 |
Manganese |
Dry ashed tissue is dissolved and quantified by AAS or by inductively coupled plasma |
0.001 ppb 0.001 ppb |
NE NE |
All/kidney, liver, muscle |
1 |
Mebendazole |
Extraction with organic solvents followed by HPLC with UV detection; extracts are confirmed by GC/EI/MS |
0.05 ppm |
NE |
Red meat/ liver, muscle |
1 |
Melengestrol acetate (MGA) |
Tissue extract is column chromatographed on Florisil and quantified by GLC |
5.0 ppb |
10.0 ppb |
Cattle/liver muscle, kidney, fat |
1 |
Extracts are derivatized with HFB and confirmed by GC/EI/MS |
5.0 ppb |
10.0 ppb |
Cattle/fat |
1 |
|
Mercury |
Tissue is digested in acid. Mercury is reduced to its vapor and quanti- fied by flameless AAS |
0.01 ppm |
0.02 ppm |
All/kidney, liver, muscle |
1 |
Methanearsonic acid |
Dry ashed tissue is dissolved and reacted to produce arsine liver, muscle gas, which is quantified by AAS |
0.05 ppm |
NE |
All/kidney, |
1 |
Dry ashed tissue is dissolved and reacted to produce arsine gas,which reacts to form blue complex for colorimetric quantification |
0.05 ppm |
0.20 ppm |
All/kidney, liver, muscle |
1 |
|
Methomyl |
GPC plus HPLC with post- column fluorescence detection |
5 ppb |
10 ppb |
All/liver |
1 |
Methoxychlor |
Micro alumina assay: column chromatography plus GLC GPC plus GLC |
0.15 ppm 0.15 ppm |
NE 0.50 ppm |
All/fat,PP All/fat |
1 1 |
Extracts from GPC or Mills are confirmed by GC/MS |
0.15 ppm |
NE |
All/fat, |
1 |
|
Methyl parathion |
Tissue extracts are quantified by GLC with flame photometric or nitrogen-phosphorous flame ionization detector |
0.10 ppm |
NE |
All/liver, muscle |
1 |
Monensin |
Tissue extract is partitioned by TLC and semi-quantified by inhibition of micro-organism growth |
0.05 ppm |
0.10 ppm |
Cattle, poultry/ liver ,fat |
1 |
| COMPOUND | Method Description |
LDL/ MIC |
MPL |
Species/ Tissues |
Reference |
Morantel tartrate |
Tissue extract is hydrolyzed and a derivative is quantified by GLC |
0.25 ppm 0.50 ppm |
0.50 ppm NE |
Cattle/liver Cattle/muscle |
1 1 |
Identification of a structurally significant hydrolyzed fragment by GC/MS |
0. 25 ppm |
NE |
Cattle/liver, muscle |
26 |
|
Narasin |
Tissue extracts are spotted on TLC and quantified with a bio-autographic overlay |
5 ppb |
NE |
Cattle, poultry/ liver, kidney, fat |
1 |
Neomycin |
Tissue is deproteinized, acidified, and extracted; quantified by HPLC/UV |
1.5 ppm |
NE |
All Kidney |
14 |
Antibiotic screen test (Swab):ability of tissue fluids containing anti-microbial activity to inhibit microbial growth |
0.25 ppm |
NE |
All/kidney |
16 |
|
Tissue extracts are screened by E-Z Screen |
5.0 ppb |
NE |
All/muscle/ liver, kidney |
10 |
|
Microbiological assay procedure: ability of tissue extracts containing antimicrobial activity to inhibit microbial growth |
0.25 |
NE |
All/kidney, liver, muscle |
27 |
|
Nequinate |
Zymark Pytechnology System: Tissue extracts are screened by HPLC/UV |
NE |
NE |
Cattle/liver, muscle |
14 |
Nicarbazin |
Tissues are extracted with ethyl acetate; the dinitrocarbanilide moiety isquantified by HPLC with a UV detector.Extracts verified by photodiode array detection |
0.1 ppm |
2.0 ppm |
Chicken/ all tissues |
1 |
Nickel |
Dry ashed tissue is dissolved and quantified by AAS or by inductively coupled plasma. |
NE NE |
NE 0.34 ppb |
All/kidney, liver, muscle All/kidney, liver, muscle |
1 1 |
Nonachlor |
Micro alumina assay: column chromatography plus GLC GPC plus GLC |
0.05 ppm 0.03 ppm |
NE 0.15 ppm |
All/fat, PP All/fat |
1 1 |
Mills method: Florisil column chromatography plus GLC |
0.05 ppm |
0.15 ppm |
All/fat,PP |
1 |
|
|
Extracts from GPC or Mills are confirmed by GC/MS |
0.05 ppm |
NE |
All/fat, PP |
1 |
|
Novobiocin |
Microbiological assay procedure: ability of tissue extracts containing antimicrobial activity to inhibit microbial growth |
0.125 ppm |
NE |
All/kidney, liver, muscle |
4 |
Zymark Pytechnology System: organic solvent extraction followed by HPLC/UV detection. |
0.50 ppm |
NE |
All/kidney, liver, muscle |
14 |
|
Manual system organic solvent extraction followed by HPLC/UV detection |
0.50 ppm |
NE |
All/kidney, liver, muscle |
1 |
|
| COMPOUND | Method Description |
LDL/ MIC |
MPL |
Species/ Tissues |
Reference |
Oleandomycin |
Antibiotic screen test (Swab): ability of tissue fluids containing antimicrobial activity to inhibit microbial growth |
0.25 ppm |
NE |
All/kidney, |
16 |
Oxfendazole |
Extraction with organic solvents followed by HPLC with UV detection; extracts are derivatized and confirmed by GC/EI/MS |
0.05 ppm |
NE |
Red meat, liver, muscle, PP |
1 |
Oxytetracycline hydrochloride |
Antibiotic screen test (Swab): ability of tissue fluids containing anti-microbial activity to inhibit microbial growth |
0.08 ppm |
NE |
All/kidney |
16 |
Microbiological assay procedure: ability of tissue extracts containing Lab antimicrobial activity to inhibit microbial growth |
0.08 ppm |
0.08 ppm |
All/kidney, liver muscle |
Sec. 6.312 |
|
Extraction using C18 columns followed by HPLC with UV detection |
0.15 ppm |
0.25 ppm |
All/kidney, liver muscle |
||
Parathion |
Tissue extracts are quantified by GLC with flame photometric ornitrogen-phosphorous flame ionization detector |
NE |
NE |
All/liver, muscle |
14 |
PBB's |
Micro alumina assay: column chromatography plus GLC detection by electron capture. UV degradation of PBB's is used as confirmation. |
0.05 ppm |
NE |
All/fat |
29 |
PCB's (reported as Aroclor 1242, 1248, 1254, 1260, etc.) |
Micro alumina assay: column chromatography plus GLC. GPC plus GLC |
0.30 ppm 0.30 ppm |
NE 0.50 ppm |
All/fat pp All/fat |
1 |
Penicillin, procaine and procaine G |
Antibiotic screen test (Swab): ability of tissue containing anti-microbial activity to inhibit microbial growth. |
12.5 ppb |
NE |
All/kidney |
16 |
Penicillin G (benzathine, free acid, sodium salt, and procaine salts) |
Microbiological assay procedure: ability of tissue extracts containing antimicrobial activity to inhibit microbial growth |
12.5 ppb |
NE |
All/kidney, liver muscle |
30 |
Pentachloroanisole |
GPC plus GC Extracts confirmed by GC/EI/MS |
NE NE |
NE NE |
Poultry/fat Poultry/fat |
14 |
Pentachlorophenol PCP |
Tissue digestate is extracted with cyclo- hexane and quantified by GLC |
0.03 ppm |
0.05 ppm |
All/liver, muscle |
1 |
Tissue extracts for GLC are confirmed by GC/MS. Extracts confirmed by GC/EI/MS |
0.03 ppm NE |
NE NE |
All/liver, muscle Poultry/fat |
1 1 |
|
Permethrin (cis & trans) |
Solvent extraction followed by a competitive ELISA determination. Organic solvent extracts are quantified as the sum of both isomers; extracts are confirmed by GC/EI/MS |
1.0 ppb 1.0 ppb |
NE NE |
All/fat All/fat |
1 1 |
Phencyclidine |
Tissue extracts are spotted for TLC with specific chromogenic agent |
NE |
NE |
All/liver, muscle |
1 |
Phenotrin |
Solvent extraction followed by a competitive ELISA determination |
1.0 ppm |
NE |
All/fat |
1 |
Phosalone |
GPC plus GLC GPC extracts are confirmed by GC/EI/MS |
0.05 ppm |
NE |
All/fat Red meat, fat |
1 1 |
| COMPOUND | Method Description |
LDL/ MIC |
MPL |
Species/ Tissues |
Reference |
Propazine |
Fat extracted using C18 columns and quantified by capillary GC detector Lab with nitrogen-phosphorous flame ionization detector. Extracts confirmed by GC/MS |
5 ppb
5 ppb |
NE
NE |
All/fat
All/fat |
1
1 |
Promecarb |
GPC plus HPLC with post- column flourescence detection. Extracts are subjected to reverse phase chromatography, derivativized and confirmed by GC/MS |
5 ppb |
10 ppb |
All/liver |
1 |
Propoxur |
GPC plus HPLC with post- column fluorescence detection. Extracts are subjected to reverse phase chromatography, derivatitized and confirmed by GC/MS |
5 ppb |
10 ppb |
All/liver |
1 |
Pyrantel tartrate |
Tissue extract is hydrolyzed and a derivative is quantified by GLC |
0.25 ppm |
0.50 ppm |
Swine/liver, muscle |
1 |
Identification of a structurally significant hydrolyzed fragment by GC/MS |
0.25 ppm |
NE |
Swine/liver, muscle |
31 |
|
Ronnel |
Tissue extracts are quantified by GLC with flame photometric or nitrogen-phosphorous flame ionization detector. GPC plus GLC |
NE
0.02 ppm |
NE
0.05 ppm |
All/liver, muscle
All/fat |
14
1 |
Extracts are confirmed by GC/EI/MS |
0.01 ppm (poultry) 0.10 ppm (red meat) |
NE
NE |
Poultry, red meat, fat |
1 |
|
Roxarsone |
Dry ashed tissue is dissolved and reacted to produce arsinegas, which is quantified by AAS. Dry ashed tissue is dissolved and reacted to produce arsine liver muscle gas, which reacts to form blue complex for colorimetric quantification |
0.05 ppm
0.05 ppm |
NE
0.20 ppm |
All/kidney, liver muscle
All/kidney |
1 1 |
Simazine |
Fat extracted using C18 columns and quantified by capillary GC with nitrogen-phosphorous detector. Extracts confirmed by GC/MS |
5 ppb
5 ppb |
NE
NE |
All/fat
All/fat |
1
1 |
Spectinomycin hydrochloride |
Microbiological assay: tissue extracts are quantified using a turbidimetric assay. |
2.8 ppm |
NE |
All/kidney, liver, muscle |
32 |
Streptomycin |
Antibiotic screen test (Swab): ability of tissue fluids containing antimicrobial activity to inhibit microbial growth Microbiological assay procedure: ability of tissue extracts containing antimicrobial activity to inhibit microbial growth
|
0.25 ppm
0.25 ppm |
NE
NE |
All/kidney
All/kidney, liver, muscle |
16
35 |
Styrene |
Tissues are subjected to GC/MS head space analysis. |
1 ppb |
NE |
All/kidney, liver, muscle fat, pp |
1 |
Sulfachloro- pyridazine |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry |
0.02 ppm |
0.05 ppm |
Red meat/ liver, muscle |
1 |
Extraction followed by GC/CI and EI/MS |
0.05 ppm |
NE |
Red meat/ liver, muscle |
1 |
|
Sulfadiazine |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry |
0.02 ppm |
0.05 ppm |
Red meat/liver, muscle |
1 |
Extraction followed by GC/CI and EI/MS |
0.05 ppm |
NE |
Red meat/liver, muscle |
1 |
|
Sulfadimethoxine |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry |
0.02 ppm |
0.05 ppm |
All/liver, muscle |
1 |
Extraction followed by GC/EI/MS Tissue extracts are screened by E-Z Screen |
0.05 ppm 50 ppb |
NE NE |
All/liver, muscle All/liver |
1 10 |
|
Sulfadoxine |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry. |
0.05 ppm |
NE |
Red meat/ liver, muscle |
1 |
Tissue extracts are confirmed by GC/EI/MS |
NE |
NE |
Red meat/ liver, muscle |
1 |
|
Sulfaethoxy- pyridazine |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry |
0.02 ppm |
0.05 ppm |
Red meat/ liver, muscle |
1 |
| COMPOUND | Method Description |
LDL/ MIC |
MPL |
Species/ Tissues |
Reference |
Sulfamethazine |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry. |
0.02 ppm |
0.05 ppm |
All/liver, muscle; Red meat/feed concentrate pp |
1 |
Tissue extracts are confirmed by GC/EI/MS |
0.05 ppm |
NE |
All/liver, muscle, pp |
1 |
|
Tissue extracts are detected by TLC fluorescence (SOS-urine) |
NE |
NE |
Swine/urine |
14 |
|
Tissue extracts are screened by E-Z Screen |
50 ppb |
NE |
All/liver |
1 |
|
Sulfamethoxy- pyridazine |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry |
0.02 ppm |
0.05 ppm |
Red meat/ liver, muscle |
1 |
Sulfaphenazole |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry |
0.05 ppm |
NE |
Red meat/ liver, muscle |
1 |
Tissue extracts are confirmed by GC/EI/MS |
NE |
NE |
Red meat/ liver, muscle |
1 |
|
Sulfapyridine |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry. |
0.02 ppm |
0.05 ppm |
All/liver, muscle |
1 |
Tissue extracts are confirmed by GC/EI/MS |
0.05 |
NE |
All/liver, muscle, pp |
1 |
|
| COMPOUND | Method Description |
LDL/ MIC |
MPL |
Species/ Tissues |
Reference |
Sulfaquinoxaline |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry. |
12.5 ppb |
25.0 ppb |
Poultry/liver, muscle |
1 |
Tissue extracts are confirmed by GC/EI/MS |
25 ppb |
NE |
Poultry/liver, muscle |
1 |
|
Sulfathiazole |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry Lab Tissue extracts are confirmed by GC/EI/MS |
0.02 ppm
0.05 ppm |
0.05 ppm
NE |
Red meat/ liver, muscle
Red meat/ liver, muscle, pp |
1
1 |
Sulfatroxazole |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry. Tissue extracts are confirmed by GC/EI/MS |
0.05 ppm
NE |
NE
NE |
Red meat/ liver, muscle
Red meat/ liver, muscle |
1
1 |
Sulfisoxazole TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry. Tissue extracts are confirmed by GC/EI/MS |
0.05 ppm
NE |
NE
NE |
Red meat/ liver, muscle
Red meat/ liver, muscle |
1
1 |
|
| COMPOUND | Method Description |
LDL/ MIC |
MPL |
Species/ Tissues |
Reference |
Sulfisoxazole |
TLC fluorescence: tissue extracts are partitioned by TLC and quantified by densitometry |
0.05 ppm |
NE |
Red meat/liver, muscle |
1 |
Tissue extracts are confirmed by GC/EI/MS |
NE |
NE |
Red meat/liver, muscle |
1 |
|
Tetrametrin |
Solvent extraction followed by a competitive ELISA determination |
1.0 ppm |
NE |
All/fat |
1 |
TDE (metabolite of DDT reported as DDT) |
Micro alumina assay: column chromatography plus GLC GPC plus GLC |
0.04 ppm 0.03 ppm |
NE 0.15 ppm |
All/fat, pp All/fat |
1 1 |
Mills method: Florisil column chromatography plus GLC Extracts from GPC or Mills are confirmed by GC/MS |
0.04 ppm
0.02 ppm |
0.15 ppm
NE |
All/fat pp
All/fat pp |
1
1 |
|
Terbuthylazine |
Fat extracted using C18 columns and quantified by capillary GC with nitrogen-phosphorous detector
|
5 ppb |
NE |
All/fat |
1 |
Extracts confirmed by GC/MS |
5 ppb |
NE |
All/fat |
1 |
|
Terpene polychlorinates |
Micro alumina assay: column chromatography plus GLC |
0.50 ppm |
NE |
All/fat |
1 |
Mills method: Florisil column chromatography plus GLC |
0.50 ppm |
NE |
All/fat |
1 |
|
Tetracycline hydrochloride |
Antibiotic screen test (Swab): ability of tissue chloride fluids containing anti-microbial activity to inhibit microbial growth |
0.08 ppm |
NE |
All/kidney |
16 |
Microbiological assay procedure: ability of tissue extracts containing antimicrobial activity to inhibit microbial growth. |
0.08 ppm |
NE |
All/kidney, liver, muscle |
34 |
|
Extraction using C18 columns followed by HPLC with UV detection. |
0.15 ppm |
0.25 ppm |
All/kidney, liver, muscle |
14 |
|
Thiabendazole |
pH extraction with organic solvents followed by HPLC with UV detection; extracts derivatized and confirmed by GC/EI/MS |
0.05 ppm |
NE |
Red meat, pp liver, muscle |
1 |
Extracts confirmed by GC/MS |
NE |
0.4 ppm |
Swine/liver |
35 |
|
| COMPOUND | Method Description |
LDL/ MIC |
MPL |
Species/ Tissues |
Reference |
Tiamulin |
Organic solvent extraction followed by GC of the 8-hydroxymutilin metabolite. |
0.2 ppm |
0.4 ppm |
Swine/liver |
35 |
Extracts confirmed by GC/MS |
NE |
0.4 ppm |
Swine/liver |
35 |
|
Tin |
Tissue is dry ashed and dissolved and quantified by AAS (used to screen for organotin compounds) |
0.02 ppm |
NE |
All/kidney, liver, muscle |
1 |
Toxaphene |
Micro alumina assay: column chromatography plus GLC |
0.50 ppm |
NE |
All/fat, pp |
1 |
GPC plus GLC Mills method: Florisil column chromatography plus GLC |
0.50 ppm 0.50 ppm |
NE 1.00 ppm |
All/fat All/fat, pp |
1 1 |
|
Trichlorfon |
Tissue extracts are quantified by GLC with flame photometric or nitrogen-phosphorous flame ionization detector |
NE |
NE |
All/liver, muscle |
1 |
Tylosin |
Antibiotic screen test (Swab): ability of tissue fluids containing anti- microbial activity to inhibit microbial growth |
0.20 ppm |
NE |
All/kidney |
|
Tissue extracts are screened by E-Z screen. Liquid-liquid extraction followed by HPLC-UV detection |
50 ppm
0.1 ppm |
NE
NE |
All/muscle, liver, kidney
Cattle/muscle |
10
14 |
|
Virginiamycin |
Microbiological assay procedure: ability of tissue extracts containing antimicrobial activity to inhibit microbial growth |
0.64 ppm |
NE |
Swine/ kidney, liver, muscle |
36 |
Organic solvent extraction followed by HPLC/UV quantification |
0.1 ppm |
NE |
All/kidney, liver, muscle |
1 |
|
Zeranol and metabolite taleranol |
Extraction followed by radioimmunoassay. Solid phase extraction using an internal standard followed liver, muscle followed by polymethyl- silation for GC/MS quantification and confirmation
|
1.0 ppb 1.0 ppb (zeranol) 4.0 ppb (taleranol) |
NE NE |
Cattle/liver, muscle Cattle, sheep |
1 1 |
Zinc |
Dry ashed tissue is dissolved and quantified by AAS or by inductively coupled plasma
|
1 ppb 2 ppb |
NE NE |
All/kidney, liver, muscle All/kidney, liver, muscle |
1 1 |
Click here for further information.
Click here to learn more about the Office of Public Health and Science.
URL: http://www.usda.gov/fsis/ophs/bluebook/racahz.htm
Last Updated On 03/09/1998.